Atlas Trials

A Prospective Study of the Disease Characteristics of Adult Patients With Long Chain Fatty Acid Oxidation Disorders

Clinical trial NCT04482049 · COMPLETED

Trial details

NCT number
NCT04482049
Sponsor
Reneo Pharma Ltd
Status
COMPLETED
Study type
OBSERVATIONAL
Fatty Acid Oxidation Disorder
Start date
2021-01-15
Primary completion
2022-05-04
Enrollment
61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.